Guys, if you haven’t been following the Valeant story. Then wake up! 🙂 This is better than Prison Break and Star Wars. Recap: VRX is pharma hedge fund darling. Largest position in Ackman’s portfolio. VRX selling point is that they don’t do R&D as it costs too much, so they acquire drug companies, fire the employees and push up the price of drugs. So huge growth, huge profits, huge valuation. US Gov has notice the rise in prices because some other pharma company overdid it. Now eyes turned to VRX. VRX “s**t” itself and announced a change is business strategy. No more acquisitions and will do R&D. Overvalued and with a lot of debt, the market sells their holdings and shorts the stock violently. (Including yours truly in my Market Neutral strategy). To make matters worse, Citron Research, comes out with a report that VRX could be the next Enron!!! See Citron’s website. Is there more? Heck yeah! Ackman has bought more shares after losing over $2 billion in 2 months as the stock dropped from $260 to $108, and VRX is giving some very confusing excuses….
Investing website that displays stock ideas, opinions and my strategies.
Disclaimer
fatalpha.com is not operated by a broker, a dealer, a registered investment adviser, or a regulated entity. Under no circumstances does any information posted represent a recommendation to buy or sell a security. In no event shall fatalpha.com, Sophocles Sophocleous, FATALPHA LTD, or any affiliates or associates be liable to any member or guest for any damages of any kind arising out of the use of any content available on the website. Past performance is a poor indicator of future performance. All the information on this site and any related materials is not intended to be, nor does it constitute investment advice or recommendations. All materials and information you obtain here are exclusively for informational purposes and does not constitute an offer or solicitation to provide any investment services to investors based in the U.S. or elsewhere.
Sophocles Sophocleous
